EUVIMEDEUVIMED entdecken
Crossref

Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients

Jasmeet Kaur

American Journal of Biomedical Sciences · 2022-04 · 58-71

DOI: 10.5099/aj220200058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Biomedical Sciences, 2022-04. Verfasst von Jasmeet Kaur. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kaur, J. (2022). Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients. American Journal of Biomedical Sciences, 58-71. https://doi.org/10.5099/aj220200058

Vancouver

Kaur J. Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients. American Journal of Biomedical Sciences. 2022:58-71. doi:10.5099/aj220200058

BibTeX
@article{Kaur2022,
  author = {Kaur, Jasmeet},
  title = {Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients},
  journal = {American Journal of Biomedical Sciences},
  year = {2022},
  pages = {58--71},
  doi = {10.5099/aj220200058}
}
Kostenlos starten →